CD44 and ovarian carcinoma: Recently, Nakamura et al. have reported that tumor-derived exosomes promote ovarian cancer cell invasion through transfer of CD44 to peritoneal MCs, highlighting the crucial role of CD44 expression in the acquisition of a mesenchymal phenotype in mesothelial cells and in the interaction of the latter with tumor cells [18].